Arbutus Biopharma (ABUS) Other Working Capital Changes (2013 - 2026)
Arbutus Biopharma (ABUS) posted quarterly Other Working Capital Changes of $195000.0 for Q1 2026, up 124.01% year-on-year from $87047.8 in Q1 2025, and up 102.03% on a QoQ basis from -$9.6 million in Q2 2025.
Arbutus Biopharma (ABUS) Other Working Capital Changes (2013 - 2026) Analysis & Trends
Arbutus Biopharma (ABUS) has reported Other Working Capital Changes for 14 consecutive years, with $195000.0 the latest figure, recorded in Q1 2026.
- Quarterly Other Working Capital Changes fell 123.8% year-over-year to -$649000.0 in Q4 2018, while the trailing twelve-month figure through Sep 2019 was -$649000.0 (down 202.37% YoY) and the FY2018 annual result came in at -$2.7 million, down 200.55% from the prior year.
- Other Working Capital Changes eased to -$649000.0 in Q4 2018 per ABUS's latest filing, from -$325000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for ABUS reached as high as $2.7 million in Q4 2017 and fell as low as -$6.7 million in Q3 2017.
- A 5-year average of -$49733.3 and a median of -$1.2 million in 2024 frame the typical range for Other Working Capital Changes.
- The largest YoY upside for Other Working Capital Changes was 4432.09% in 2022 against a maximum downside of 2550.24% in 2022.
- Year by year, Other Working Capital Changes stood at $2.7 million in 2017, then plunged by 123.8% to -$649000.0 in 2018.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$649000.0, -$325000.0, and -$746000.0 for Q4 2018, Q3 2018, and Q2 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arbutus Biopharma | 880.36 Mn | 785.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 195,000.00 |
| Mar 31, 2026 | 195,000.00 |
| Mar 31, 2026 | 195,000.00 |
| Jun 30, 2025 | -9.62 Mn |
| Jun 30, 2025 | -9.62 Mn |
| Jun 30, 2025 | -9.62 Mn |
| Mar 31, 2025 | -812,000.00 |
| Mar 31, 2025 | -812,000.00 |
| Mar 31, 2025 | -812,000.00 |
| Dec 31, 2024 | -1.15 Mn |
| Dec 31, 2024 | -1.15 Mn |
| Dec 31, 2024 | -1.15 Mn |
| Sep 30, 2024 | -388,000.00 |
| Sep 30, 2024 | -388,000.00 |
| Sep 30, 2024 | -388,000.00 |
| Jun 30, 2024 | -513,000.00 |
| Jun 30, 2024 | -513,000.00 |
| Jun 30, 2024 | -513,000.00 |
| Mar 31, 2024 | -244,000.00 |
| Mar 31, 2024 | -244,000.00 |